Stocks to sell

What’s the latest with Clover Health (NASDAQ:CLOV) stock? To be honest, not much. Since I last wrote about CLOV stock on Sept. 16, the situation with the meme stock favorite hasn’t changed. The Medicare Advantage plan provider’s key issue, its challenges to become profitable, is still CLOV’s biggest challenge. Source: Shutterstock Along with this, the

Camber Energy (NYSE:CEI) is best seen as a holding company with a 62% interest in another oil and gas company, Viking Energy (OTCMKTS:VKIN). The issue is CEI stock has spiked on a speculative deal it recently signed with a third company, privately held ESG Clean Energy (“ESG”). Source: Shutterstock ESG says it has a way

Globalstar (NYSEAMERICAN:GSAT) is a highly speculative global satellite company that is coming off peak speculation. GSAT stock peaked at $2.69 on hopes that Apple (NASDAQ:AAPL) was going to sign up with the company. When that didn’t happen during a recent Sept. 14 conference, the stock started falling. Unfortunately, it probably has much lower to go.

Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker

A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors

Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more

Greenidge Generation Holdings (NASDAQ:GREE) stock closed its first day of trading as a public company, with down 58%. Source: Mark Agnor / Shutterstock.com In the six days of trading since then, it’s lost another 41%. It trades today at just above $25. Based on 9.63 million Class A and 29.04 Class B shares outstanding, the bitcoin/power

MicroVision (NASDAQ:MVIS) is still up for sale, at least according to the company’s latest 10-Q report. The reason is pretty simple. It still only has one customer for its Lidar products. And that is on a royalty revenue basis. This leaves MVIS stock fairly overvalued at the present time. Source: shutterstock.com/temp-64GTX I have written about

I can understand why people like ContextLogic (NASDAQ:WISH) stock. There are some compelling reasons why you’d want to root for this underdog. Source: sdx15 / Shutterstock.com Unfortunately, there aren’t enough of those reasons based in fact to make WISH stock a very compelling investment. So, as much as it would be fun to put your

Tesla (NASDAQ:TSLA) created the electric car market, starting with the luxury end and working down. Source: Sheila Fitzgerald / Shutterstock.com This has made CEO Elon Musk a centi-billionaire. TSLA stock was worth $741 billion as trading began September 22. The company was only marginally profitable until its June quarter report showed it bringing nearly $1

Restaurant stocks have had a challenging couple of years now. The U.S. economy was almost on full throttle earlier this year, nearly hitting escape velocity from the pandemic. But things turned around as the year progressed. Now we sit on variety of conflicting economic indicators — some encouraging, other flashing warning signs. And so, while

Peloton Interactive (NASDAQ:PTON) is wildly overvalued at its present valuation of $30.3 billion. A major reason is that the company’s latest quarter showed a massive loss in free cash flow. This adds up to a cash crunch for Peloton sometime in the near future if this trend continues. And that is not going to fare

Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration

When I wrote about Nio (NYSE:NIO) last month, I argued that the risks that could send NIO stock lower outweighed factors that could help it bounce back. Source: Robert Way / Shutterstock.com The Chinese electric vehicle (EV) maker has numerous strengths, such as high projected rates of growth in its home market. It also has

It’s an exciting time on Wall Street. Broader market indices, including the S&P 500 and Nasdaq 100, are hovering near all-time highs. But while leading stocks continue to deliver lucrative returns, many businesses have gone through a volatile summer. Those companies with shaky fundamentals, such as special purpose acquisition companies (SPSCs) or unprofitable tech firms, have recently

Aterian (NASDAQ:ATER) is a consumer products platform that, according to Yahoo! Finance, uses software which implements “machine learning, natural language processing, and data analytics to design, develop, market, and sell products.” Essentially, Aterian scales consumer brands. But what should you know about ATER stock? Source: Shutterstock This company calls itself a “leading consumer product platform” —

AT&T (NYSE:T) stock still is dealing with its troubled media divestitures. Source: Roman Tiraspolsky / Shutterstock.com The company announced that it had sold Playdemic, WarnerMedia’s mobile gaming company, to Electronic Arts (NASDAQ:EA) for $1.4 billion. Playdemic is best known for Golf Clash, an award-winning game with more than 80 million downloads worldwide. The sale is

As one of the most widely followed SPAC offerings this year, Clover Health (NASDAQ:CLOV) has not exactly set the world on fire. After debuting on Jan. 8, the stock has mostly drifted downward with the exception of a short-term trading boost earlier this summer. CLOV stock currently has a $3.4 billion market capitalization and $412

Down 42% year-to-date, ChargePoint (NYSE:CHPT) stock does not look worthy of investor’s money. Source: JL IMAGES / Shutterstock.com The largest manufacturer of electric vehicle charging stations in the world looks good on paper, but so far its potential has not translated into success for shareholders. ChargePoint went public earlier this year at the height of the

Vinco Ventures (NASDAQ:BBIG) stock is the latest meme play. But if you blink, you might miss it. Source: Michael Vi via Shutterstock Vinco is an investment company that has gotten into non fungible tokens (NFTs), launching an E-NFT platform for trading them. It also owns 80% of a short video content platform (think TikTok) called